机译:用Dabigatran eDexilate增加心肌梗死的风险:事实或虚构? 一体化的核心分析来自整合随机对照试验和现实世界研究:葡萄酒或斯普利策?
Department of Cardiology Pulmonology and Vascular Medicine Medical Faculty of the Heinrich Heine;
Department of Cardiology Pulmonology and Vascular Medicine Medical Faculty of the Heinrich Heine;
Department of Cardiology Pulmonology and Vascular Medicine Medical Faculty of the Heinrich Heine;
Department of Cardiology Pulmonology and Vascular Medicine Medical Faculty of the Heinrich Heine;
Department of Cardiology Pulmonology and Vascular Medicine Medical Faculty of the Heinrich Heine;
Department of Cardiology LMU München;
Anticoagulation; Dabigatran; Myocardial infarction;
机译:用Dabigatran eDexilate增加心肌梗死的风险:事实或虚构? 一体化的核心分析来自整合随机对照试验和现实世界研究:葡萄酒或斯普利策?
机译:对稿件评论的回应:随着Dabigatran eDexilate的增加的心肌梗死风险:事实或虚构? 一体化的核心分析来自整合随机对照试验和现实世界研究:葡萄酒或斯普利策?
机译:用Dabigatran eDexilate增加心肌梗死的风险:事实或虚构? 超过58,000名患者的关键荟萃分析从整合随机对照试验和现实世界研究
机译:缺血后后处理对再灌注心肌梗死微血管阻塞的影响。患者随机研究的结果和猪的实验模型
机译:心肌梗死后患者疾病管理计划的制定,实施和评估:一项随机对照试验。
机译:达比加群酯和心肌梗死其他心血管事件大出血和全因死亡率的风险:随机对照试验的系统评价和荟萃分析
机译:达比加群酯和心肌梗死,其他心血管事件,大出血和全因死亡率的风险:随机对照试验的系统评价和荟萃分析